MedPath

A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis

Phase 2
Completed
Conditions
Multiple Sclerosis
Interventions
Drug: ONO-4641 placebo
Registration Number
NCT01081782
Lead Sponsor
Ono Pharma USA Inc
Brief Summary

The objective of this study is to evaluate the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis over a 26-week treatment period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
407
Inclusion Criteria
  • Adult male or female aged 18-55 years inclusive at screening
  • Patients who have a definite diagnosis of relapsing-remitting Multiple Sclerosis
Exclusion Criteria
  • Multiple Sclerosis course other than relapsing-remitting multiple sclerosis
  • History of malignancy
  • History of clinically significant chronic disease of the immune system (other than Multiple Sclerosis)
  • Inability to undergo Gd-enhanced MRI scans
  • Diagnosis of diabetes mellitus (type I or type II)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
E1ONO-4641-
E3ONO-4641-
PONO-4641 placebo-
E2ONO-4641-
Primary Outcome Measures
NameTimeMethod
Total number of T-1-weighted Gd-enhanced lesions obtained with MRI at 4-week intervals for 26 weeks.26 weeks
Secondary Outcome Measures
NameTimeMethod
Total volume of Gd-enhanced lesions26 weeks

Trial Locations

Locations (86)

Donetsk Clinical Site 345

πŸ‡ΊπŸ‡¦

Donetsk, Ukraine

Tucson Clinical Site 133

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

Aurora Clinical Site 132

πŸ‡ΊπŸ‡Έ

Aurora, Colorado, United States

Sarasota Clinical Site 116

πŸ‡ΊπŸ‡Έ

Sarasota, Florida, United States

Lebanon Clinical Site 115

πŸ‡ΊπŸ‡Έ

Lebanon, New Hampshire, United States

Northbrook Clinical Site 135

πŸ‡ΊπŸ‡Έ

Northbrook, Illinois, United States

Sarasota Clinical Site 117

πŸ‡ΊπŸ‡Έ

Sarasota, Florida, United States

Round Rock Clinical Site 107

πŸ‡ΊπŸ‡Έ

Round Rock, Texas, United States

Fairfield Clinical Site 110

πŸ‡ΊπŸ‡Έ

Fairfield, Connecticut, United States

Warszawa Clinical Site 308

πŸ‡΅πŸ‡±

Warszawa, Poland

Kanto Region Clinical Site 406

πŸ‡―πŸ‡΅

Kanto, Japan

Fort Collins Clinical Site 123

πŸ‡ΊπŸ‡Έ

Fort Collins, Colorado, United States

Yaroslavl Clinical Site 331

πŸ‡·πŸ‡Ί

Yaroslavl, Russian Federation

Ufa Clinical Site 326

πŸ‡·πŸ‡Ί

Ufa, Russian Federation

Farmington Hills Clinical Site 126

πŸ‡ΊπŸ‡Έ

Farmington Hills, Michigan, United States

Knoxville Clinical Site 134

πŸ‡ΊπŸ‡Έ

Knoxville, Tennessee, United States

Philadelphia Clinical Site 120

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Bialystok Clinical Site 305

πŸ‡΅πŸ‡±

Bialystok, Poland

Czeladz Clinical Site 303

πŸ‡΅πŸ‡±

Czeladz, Poland

Gdansk Clinical Site 302

πŸ‡΅πŸ‡±

Gdansk, Poland

Chelyabinsk Clinical Site 322

πŸ‡·πŸ‡Ί

Chelyabinsk, Russian Federation

Montreal Clinical Site 102

πŸ‡¨πŸ‡¦

Quebec, Canada

Kinki Region Clinical Site 401

πŸ‡―πŸ‡΅

Kinki, Japan

Essen Clinical Site 222

πŸ‡©πŸ‡ͺ

Essen, Germany

Tohoku Region Clinical Site 403

πŸ‡―πŸ‡΅

Tohoku, Japan

Akron Clinical Site 112

πŸ‡ΊπŸ‡Έ

Akron, Ohio, United States

Olomouc Clinical Site 212

πŸ‡¨πŸ‡Ώ

Olomouc, Czech Republic

Lodz Clinical Site 306

πŸ‡΅πŸ‡±

Lodz, Poland

Ormond Beach Clinical Site 129

πŸ‡ΊπŸ‡Έ

Ormond Beach, Florida, United States

Mainz Clinical Site 231

πŸ‡©πŸ‡ͺ

Mainz, Germany

Montreal Clinical Site 113

πŸ‡¨πŸ‡¦

Quebec, Canada

Kanto Region Clinical Site 409

πŸ‡―πŸ‡΅

Kanto, Japan

Kinki Region Clinical Site 407

πŸ‡―πŸ‡΅

Kinki, Japan

Moscow Clinical Site 332

πŸ‡·πŸ‡Ί

Moscow, Russian Federation

Giessen Clinical Site 221

πŸ‡©πŸ‡ͺ

Giessen, Germany

Tohoku Region Clinical Site 410

πŸ‡―πŸ‡΅

Tohoku, Japan

Vancouver Clinical Site 131

πŸ‡¨πŸ‡¦

British Columbia, Canada

Katowice Clinical Site 309

πŸ‡΅πŸ‡±

Katowice, Poland

Kinki Region Clinical Site 408

πŸ‡―πŸ‡΅

Kinki, Japan

Tubingen Clinical Site 226

πŸ‡©πŸ‡ͺ

Tubingen, Germany

Greenfield Park Clinical Site 109

πŸ‡¨πŸ‡¦

Greenfield Park, Quebec, Canada

Kyiv Clinical Site 344

πŸ‡ΊπŸ‡¦

Kyiv, Ukraine

Vinnytsya Clinical Site 342

πŸ‡ΊπŸ‡¦

Vinnytsya, Ukraine

Girona Clinical Site 254

πŸ‡ͺπŸ‡Έ

Girona, Spain

Seattle Clinical Site 118

πŸ‡ΊπŸ‡Έ

Seattle, Washington, United States

Brugge Clinical Site 203

πŸ‡§πŸ‡ͺ

Brugge, Belgium

La Louviere Clinical Site 201

πŸ‡§πŸ‡ͺ

La Louviere, Belgium

Sijsele Clinical Site 202

πŸ‡§πŸ‡ͺ

Sijsele, Belgium

Detroit Clinical Site 104

πŸ‡ΊπŸ‡Έ

Detroit, Michigan, United States

Berlin Clinical Site 223

πŸ‡©πŸ‡ͺ

Berlin, Germany

Thessaloniki Clinical Site 245

πŸ‡¬πŸ‡·

Thessaloniki, Greece

Fort Wayne Clinical Site 111

πŸ‡ΊπŸ‡Έ

Fort Wayne, Indiana, United States

Indianapolis Clinical Site 121

πŸ‡ΊπŸ‡Έ

Indianapolis, Indiana, United States

Rochester Clinical Site 108

πŸ‡ΊπŸ‡Έ

Rochester, New York, United States

HighPoint Clinical Site 128

πŸ‡ΊπŸ‡Έ

HighPoint, North Carolina, United States

Albuquerque Clinical Site 106

πŸ‡ΊπŸ‡Έ

Albuquerque, New Mexico, United States

Gatineau Clinical Site 114

πŸ‡¨πŸ‡¦

Gatineau, Quebec, Canada

Praha 5 Clinical Site 213

πŸ‡¨πŸ‡Ώ

Praha 5, Czech Republic

Athens Clinical Site 243

πŸ‡¬πŸ‡·

Athens, Greece

Kanto Region Clinical Site 404

πŸ‡―πŸ‡΅

Kanto, Japan

Marburg Clinical Site 228

πŸ‡©πŸ‡ͺ

Marburg, Germany

Leipzig Clinical Site 229

πŸ‡©πŸ‡ͺ

Leipzig, Germany

Munster Clinical Site 225

πŸ‡©πŸ‡ͺ

Munster, Germany

Kanto Region Clinical Site 405

πŸ‡―πŸ‡΅

Kanto, Japan

Ulm Clinical Site 230

πŸ‡©πŸ‡ͺ

Ulm, Germany

Plewiska Clinical Site 304

πŸ‡΅πŸ‡±

Plewiska, Poland

Krakow Clinical Site 307

πŸ‡΅πŸ‡±

Krakow, Poland

Novosibirsk Clinical Site 324

πŸ‡·πŸ‡Ί

Novosibirsk, Russian Federation

St. Petersburg Clinical Site 325

πŸ‡·πŸ‡Ί

St. Petersburg, Russian Federation

Kaluga Clinical Site 328

πŸ‡·πŸ‡Ί

Kaluga, Russian Federation

Kazan Clinical Site 333

πŸ‡·πŸ‡Ί

Kazan, Russian Federation

Nizhniy Novgorod Clinical Site 321

πŸ‡·πŸ‡Ί

Nizhniy Novgorod, Russian Federation

St. Petersburg Clinical Site 327

πŸ‡·πŸ‡Ί

St. Petersburg, Russian Federation

Samara Clinical Site 328

πŸ‡·πŸ‡Ί

Samara, Russian Federation

Barcelona Clinical Site 253

πŸ‡ͺπŸ‡Έ

Barcelona, Spain

Bilbao Clinical Site 255

πŸ‡ͺπŸ‡Έ

Bilbao, Spain

Hospitalet de Llobregat Clinical Site 251

πŸ‡ͺπŸ‡Έ

Hospitalet de Llobregat, Spain

Barcelona Clinical Site 252

πŸ‡ͺπŸ‡Έ

Barcelona, Spain

Sevilla Clinical Site 256

πŸ‡ͺπŸ‡Έ

Sevilla, Spain

Dnipropetrovsk Clinical Site 341

πŸ‡ΊπŸ‡¦

Dnipropetrovsk, Ukraine

Lviv Clinical Site 343

πŸ‡ΊπŸ‡¦

Lviv, Ukraine

Charlotte Clinical Site 125

πŸ‡ΊπŸ‡Έ

Charlotte, North Carolina, United States

Raleigh Clinical Site 103

πŸ‡ΊπŸ‡Έ

Raleigh, North Carolina, United States

Pardubice Clinical Site 211

πŸ‡¨πŸ‡Ώ

Pardubice, Czech Republic

Ostrava Clinical Site 214

πŸ‡¨πŸ‡Ώ

Ostrava, Czech Republic

Kharkiv Clinical Site 346

πŸ‡ΊπŸ‡¦

Kharkiv, Ukraine

Β© Copyright 2025. All Rights Reserved by MedPath